Holdings
Stempoint Capital LP
As of Jun 30, 2026, Stempoint Capital LP reported 64 positions worth US$528M. Largest: Tango Therapeutics, Inc., Abivax Sa and Revolution Medicines, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Tango Therapeutics, Inc. | 1.22M | US$38.2M | held for review | Jun 30, 2026 |
| Abivax Sa | 284K | US$37.8M | held for review | Jun 30, 2026 |
| Revolution Medicines, Inc. | 160K | US$30M | held for review | Jun 30, 2026 |
| Erasca, Inc. | 1.57M | US$28.7M | held for review | Jun 30, 2026 |
| Tyra Biosciences, Inc. | 633K | US$20.2M | held for review | Jun 30, 2026 |
| Dianthus Therapeutics, Inc. | 201K | US$19.6M | held for review | Jun 30, 2026 |
| Enliven Therapeutics, Inc. | 347K | US$17.6M | held for review | Jun 30, 2026 |
| Mineralys Therapeutics, Inc. | 603K | US$16.3M | held for review | Jun 30, 2026 |
| Biohaven Ltd. | 1.06M | US$15.8M | held for review | Jun 30, 2026 |
| Surrozen, Inc. | 603K | US$13.8M | held for review | Jun 30, 2026 |